海正药业

- 600267

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
海正药业(600267) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入524,346.81272,661.531,037,307.20870,089.54606,010.31
营业收入524,346.81272,661.531,037,307.20870,089.54606,010.31
二、营业总成本490,747.58257,801.831,013,441.98811,548.44556,400.17
营业成本317,903.29174,082.48618,882.08510,754.88354,150.25
营业税金及附加4,391.862,691.128,494.225,977.193,300.24
销售费用99,987.3647,041.10236,835.75180,422.60123,660.91
管理费用43,457.9221,274.0790,867.2868,326.1543,972.06
财务费用7,252.533,794.7119,167.3314,873.8810,245.50
研发费用17,754.628,918.3639,195.3231,137.9521,071.20
资产减值损失----------
公允价值变动收益-11.68-2.1827.83139.8716.37
投资收益17,020.8512,262.076,605.577,182.829,843.71
其中:对联营企业和合营企业的投资收益1,954.991,338.71-6,037.30-4,289.13-1,756.17
汇兑收益----------
三、营业利润48,807.0727,288.108,944.3062,906.9155,025.64
加:营业外收入225.2126.34172.1396.2882.89
减:营业外支出475.86255.5317,403.104,923.264,758.25
其中:非流动资产处置损失----------
四、利润总额48,556.4227,058.91-8,286.6758,079.9350,350.28
减:所得税费用5,153.472,423.921,414.8210,518.966,970.04
五、净利润43,402.9524,635.00-9,701.5045,819.9441,583.42
归属于母公司所有者的净利润43,524.1424,853.13-9,317.1344,238.2540,413.88
少数股东损益-121.19-218.13-384.371,581.691,169.54
六、每股收益
基本每股收益(元/股)0.37000.2100-0.08000.38000.3500
稀释每股收益(元/股)0.37000.2100-0.08000.38000.3200
七、其他综合收益-108.28-71.73131.18207.97316.55
八、综合收益总额43,294.6624,563.27-9,570.3147,499.4143,427.27
归属于母公司所有者的综合收益总额43,415.8524,781.40-9,185.9545,917.7342,257.73
归属于少数股东的综合收益总额-121.19-218.13-384.371,581.691,169.54
下载全部历史数据到excel中 返回页顶